Picks for 12/4/20

Watching some new tickers this morning in addition to some picked previously.

I am watching:

XTNT - Watching this for a potential swing trade. I like this chart. The MACD is crossing and yesterday there was a small gap up to open. I like the multiple bottom in early November around the $1.10 range which established support. I would like to see it break $1.42 to enter for a swing.

$1.62 first target

$1.79 second target

EMKR - I picked this on 12/2 and it has moved as expected. I am going to stick with this one for a swing.

I am also closely watching:

CEMI. I added to my swing position in the premarket after it sold off heavily. The sell-off was due to a response from the FDA that states: "THAT THE FDA HAS DETERMINED THAT REVIEW OF IGM/IGG EUA REQUEST IS NOT A PRIORITY" In my opinion, the sell off is not justified.

BCRX - BioCryst Announced FDA Approval of ORLADEYO™. This may offer some intraday trading opportunities.

VERI and JMIA continue to look strong and will likely present intraday opportunities. ADIL and EGAN still on watch.

61 views0 comments

Recent Posts

See All

TG - Originally picked this on 2/17 and after hitting my target it has retraced and appears to be setting up again with a recent MACD cross and close above the .5 fib level are very bullish . Also h

EXTN - Hit my prior target ($7.36) in 15 trading days. I remain bullish and up the target to $8.09 Also watching: AUY, BKR, ARKO, FTI, TG

ELMD - We see a series of higher lows since November 2020 and a recent break out above the descending trend line on the weekly chart ( wedge ). Also the MACD is crossing over and momentum recently c